Viewing Study NCT02427451


Ignite Creation Date: 2025-12-24 @ 11:53 PM
Ignite Modification Date: 2025-12-27 @ 11:25 PM
Study NCT ID: NCT02427451
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-01-12
First Post: 2015-03-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bcl-2 Inhibitor GDC-0199 in Combination With Obinutuzumab and Ibrutinib in Treating Patients With Relapsed, Refractory, or Previously Untreated Chronic Lymphocytic Leukemia
Sponsor: Kerry Rogers
Organization: